Literature DB >> 15779223

Comparison of the degree of pulpal anesthesia achieved with the intraosseous injection and infiltration injection using 2% lidocaine with 1:100,000 epinephrine.

John Nusstein1, Mark Wood, Al Reader, Mike Beck, Joel Weaver.   

Abstract

This prospective, randomized study compared the degree of pulpal anesthesia obtained from an intraosseous injection to an infiltration injection that used 2% lidocaine with 1:100,000 epinephrine. The success rate for the intraosseous injection was 98%; for the infiltration injection, the success rate was 85%. There was no significant difference between the two techniques. The mean time for the onset of pulpal anesthesia was significantly faster with the intraosseous injection and the infiltration injection resulted in a significantly longer duration of pulpal anesthesia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15779223

Source DB:  PubMed          Journal:  Gen Dent        ISSN: 0363-6771


  12 in total

1.  A prospective, randomized, double-blind comparison of 2% lidocaine with 1:100,000 epinephrine, 4% prilocaine with 1:200,000 epinephrine, and 4% prilocaine for maxillary infiltrations.

Authors:  Steven Katz; Melissa Drum; Al Reader; John Nusstein; Mike Beck
Journal:  Anesth Prog       Date:  2010

2.  A prospective, randomized, double-blind comparison of 2% mepivacaine with 1 : 20,000 levonordefrin versus 2% lidocaine with 1 : 100,000 epinephrine for maxillary infiltrations.

Authors:  Ingrid Lawaty; Melissa Drum; Al Reader; John Nusstein
Journal:  Anesth Prog       Date:  2010

Review 3.  Anatomy of sodium hypochlorite accidents involving facial ecchymosis - a review.

Authors:  Wan-chun Zhu; Jacqueline Gyamfi; Li-na Niu; G John Schoeffel; Si-ying Liu; Filippo Santarcangelo; Sara Khan; Kelvin C-Y Tay; David H Pashley; Franklin R Tay
Journal:  J Dent       Date:  2013-08-28       Impact factor: 4.379

4.  Anesthetic efficacy of 3 volumes of lidocaine with epinephrine in maxillary infiltration anesthesia.

Authors:  Paula Cristina Brunetto; José Ranali; Gláucia Maria Bovi Ambrosano; Patrícia Cristine de Oliveira; Francisco Carlos Groppo; John Gerard Meechan; Maria Cristina Volpato
Journal:  Anesth Prog       Date:  2008

5.  Pulpal Anesthesia of Adjacent Teeth Following Infiltration of 2% Lidocaine With 1:100,000 Epinephrine in the Maxillary Lateral Incisor and First Molar.

Authors:  Sara Fowler; Melissa Drum; Al Reader; John Nusstein; Mike Beck
Journal:  Anesth Prog       Date:  2019

6.  Anesthetic efficacy of a combination of 0.5 M mannitol plus 36.8 mg of lidocaine with 18.4 μg epinephrine in maxillary infiltration: a prospective, randomized, single-blind study.

Authors:  Kevin Younkin; Al Reader; Melissa Drum; John Nusstein; Mike Beck
Journal:  Anesth Prog       Date:  2014

7.  Intraosseous anesthesia with solution injection controlled by a computerized system versus conventional oral anesthesia: a preliminary study.

Authors:  Rut Beneito-Brotons; David Peñarrocha-Oltra; Javier Ata-Ali; María Peñarrocha
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-05-01

8.  Side effects and complications of intraosseous anesthesia and conventional oral anesthesia.

Authors:  David Peñarrocha-Oltra; Javier Ata-Ali; María-José Oltra-Moscardó; María Peñarrocha-Diago; Miguel Peñarrocha
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-05-01

9.  Comparative study between manual injection intraosseous anesthesia and conventional oral anesthesia.

Authors:  D Peñarrocha-Oltra; J Ata-Ali; M-J Oltra-Moscardó; M-A Peñarrocha-Diago; M Peñarrocha
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-03-01

10.  The effect of single buccal infiltration anesthesia of 4% articaine with either 1:100,000 or 1:200,000 epinephrine on pulpal blood flow and anesthesia of maxillary first molars and second premolars in humans.

Authors:  Kanittha Kijsamanmith; Chayanit Sriworapongpun; Nichanan Pawasut; Nadpatchamon Huayhongthong; Thanawin Sakulyuenyong; Piyatida Krongyoungyuen; Tshering Samdrup
Journal:  Clin Oral Investig       Date:  2021-05-26       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.